Capital World Investors
ONC

Capital World Investors’s BeOne Medicines Ltd ONC Stock Holding History

Capital World Investors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$641M Buy
2,249,582
+626,895
+39% +$185M 0.08% 193
2026
Q1 		$482M Buy
+1,622,687
New +$525M 0.07% 208
2018
Q3 		– Sell
-1,828,239
Closed -$281M – 599
2018
Q2 		$281M Buy
1,828,239
+1,292,029
+241% +$230M 0.06% 213
2018
Q1 		$90.1M Buy
+536,210
New +$72.6M 0.02% 302

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors's ONC Position: Q2 2026 in Review

Capital World Investors increased its BeOne Medicines Ltd (ONC) stake by 39% in Q2 2026, buying an estimated $185M and bringing the position to 2,249,582 shares worth $641M. The position accounts for 0.08% of the portfolio, ranked #193.

Capital World Investors first reported a position in ONC in Q1 2018 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Capital World Investors held 2,249,582 shares of BeOne Medicines Ltd worth $641M as of Q2 2026.
  • Capital World Investors bought 626,895 BeOne Medicines Ltd shares in Q2 2026, an estimated $185M.
  • BeOne Medicines Ltd made up 0.08% of Capital World Investors's portfolio in Q2 2026, its #193 holding.
  • Capital World Investors first reported a position in BeOne Medicines Ltd in Q1 2018 and has held it in 4 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.